SCHEMBL645307

SCHEMBL645307

COc1ccc(Cl)cc1CN(C)S(=O)(=O)c1cc(-c2nnc(O)n2-c2ccccc2C)c(O)cc1O

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 7/20 0.43
HSP90AB1 P08238 4/20 0.43
RAB9A P51151 2/20 0.37
ALDH1A1 P00352 5/20 0.36
NPSR1 Q6W5P4 4/20 0.36
KMT2A Q03164 3/20 0.36
TSHR P16473 2/20 0.36
MEN1 O00255 2/20 0.35
GAA P10253 3/20 0.34
LMNA P02545 3/20 0.34
MAPT P10636 1/20 0.34
MAPK1 P28482 1/20 0.34
ALPL P05186 1/20 0.34
KEAP1 Q14145 1/20 0.34
NFE2L2 Q16236 1/20 0.34
TP53 P04637 1/20 0.33
POLB P06746 1/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL644660 0.93 HSP90AA1 (0.47) HSP90AA1HSP90AB1RAB9AALDH1A1NPSR1
SCHEMBL647555 0.92 HSP90AA1 (0.49) HSP90AA1HSP90AB1RAB9AALDH1A1NPSR1
SCHEMBL645831 0.91 HSP90AA1 (0.51) HSP90AA1HSP90AB1KMT2AGAAKEAP1
SCHEMBL644896 0.91 HSP90AA1 (0.45) HSP90AA1HSP90AB1ALDH1A1NPSR1KMT2A
SCHEMBL644594 0.88 HSP90AA1 (0.39) HSP90AA1HSP90AB1ALDH1A1
SCHEMBL646377 0.87 HSP90AA1 (0.47) HSP90AA1HSP90AB1ALDH1A1LMNAKEAP1
SCHEMBL645341 0.86 HSP90AA1 (0.44) HSP90AA1HSP90AB1ALDH1A1NPSR1KMT2A
SCHEMBL646699 0.86 HSP90AA1 (0.49) HSP90AA1HSP90AB1ALDH1A1TSHRGAA
SCHEMBL645804 0.86 HSP90AA1 (0.47) HSP90AA1HSP90AB1ALDH1A1NPSR1KMT2A
SCHEMBL645469 0.85 HSP90AA1 (0.42) HSP90AA1HSP90AB1LMNAMAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2023922-B1 TRIAZOLE DERIVATIVES II MERCK PATENT GMBH (DE) 2012-07-11 EP claimed
US-8119795-B2 Triazole derivatives II MERCK PATENT GMBH (DE) 2012-02-21 US claimed
US-20100022540-A1 TRIAZOLE DERIVATIVES II MERCK PATENT GESELLSCHAFT (DE) 2010-01-28 US claimed
EP-2023922-B1 TRIAZOLE DERIVATIVES II MERCK PATENT GMBH (DE) 2012-07-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100022540-A1 TRIAZOLE DERIVATIVES II HSP90AB1, HSP90AA1, HSP90AB2P HSP90AA1 2/4885HSP90AB1 1/4885RAB9A 2229/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.